Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, Niloff J, Cannistra S. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte-colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Gyn Oncol 2000; 77: 271.
5. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet Jean-Sebastien, Narod SA. BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer. Am J Hum Gen 2000; 66 (4):1259..
7. Syngal S, Scgrag D, Flachuk M, Tung N, Farraye FA, Chung D, Wright M, Whetsell A, Miller G, Garber JE. Phenotypic Characteristics Associated With the APC Gene I1307K Mutation in Ashkenazi Jewish Patients With Colorectal Polyps. JAMA 2000; 284:857.
10. Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J, Weber B, Karlan B, Fishman D, Rosen B, Tung N, Neuhausen SL. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (2001 May 12) 357 (9267): 1467-70.
Major Collaborative Activities:
BReast cancer SPORE grant through DF/HCC- I am an investigator on 2 projects and work with Frd Li on the High risk CORE.
